Candida dubliniensis at a university hospital in Saudi Arabia
- PMID: 12734225
- PMCID: PMC154754
- DOI: 10.1128/JCM.41.5.1907-1911.2003
Candida dubliniensis at a university hospital in Saudi Arabia
Abstract
Candida dubliniensis is a newly described yeast species that is a close phylogenetic relative of C. albicans. Although it has been reported from different parts of the world, no detailed investigation of this species has been done in Saudi Arabia. The purpose of the present study was to identify C. dubliniensis isolates recovered from clinical specimens at a tertiary-care hospital in Riyadh, Saudi Arabia, and to determine the drug susceptibility profiles of those isolates. Over a period of 8 months, 823 germ tube- and chlamydospore-positive yeasts identified as C. albicans and recovered from different clinical specimens were screened for their ability to grow at 45 degrees C on Sabouraud dextrose agar. Isolates which failed to grow at 45 degrees C were presumptively identified as C. dubliniensis. The species identities were further confirmed by the production of pseudohyphae and chlamydospores on Staib agar and their inability to assimilate D-xylose and alpha-methyl-D-glucoside by using the API 20C AUX system. A total of 27 (3.3%) isolates were identified as C. dubliniensis. They were all recovered from 23 human immunodeficiency virus-negative patients. The prevalence of C. dublinensis in bronchoalveolar lavage (33.3%), oral (16.7%), and blood (16.7%) specimens was high. In addition, 33 isolates previously identified as C. albicans and preserved among our stock blood culture isolates were also recruited for the study. Of these, 5 isolates were found to be C. dubliniensis, thus making the total number of isolates identified as this species 32. Antifungal susceptibility testing of the C. dubliniensis isolates showed 100% sensitivity to amphotericin B, 97% sensitivity to each of fluconazole and ketoconazole, and 87.5% sensitivity to itraconazole. However, in contrast to other studies, the majority of the isolates (65.6%) showed high levels of resistance to flucytosine (MIC > 64 microg/ml). Further studies are warranted to investigate the cause of this unusually high rate of resistance to flucytosine of the C. dubliniensis isolates in this region.
Similar articles
-
Prevalence of Candida dubliniensis among germ tube-positive yeasts recovered from the respiratory specimens in HIV-negative patients.Mycoses. 2004 Apr;47(3-4):150-5. doi: 10.1111/j.1439-0507.2004.00973.x. Mycoses. 2004. PMID: 15078432
-
Isolation and molecular identification of Candida dubliniensis from non-human immunodeficiency virus-infected patients in Kuwait.J Med Microbiol. 2004 Jul;53(Pt 7):633-637. doi: 10.1099/jmm.0.05315-0. J Med Microbiol. 2004. PMID: 15184534
-
Identification of Candida dubliniensis based on temperature and utilization of xylose and alpha-methyl-D-glucoside as determined with the API 20C AUX and vitek YBC systems.J Clin Microbiol. 1999 Dec;37(12):3804-8. doi: 10.1128/JCM.37.12.3804-3808.1999. J Clin Microbiol. 1999. PMID: 10565888 Free PMC article.
-
Candida dubliniensis, a new fungal pathogen.J Basic Microbiol. 2002;42(3):207-27. doi: 10.1002/1521-4028(200206)42:3<207::AID-JOBM207>3.0.CO;2-C. J Basic Microbiol. 2002. PMID: 12111748 Review.
-
Meningitis Caused by Candida Dubliniensis in a Patient with Cirrhosis: A Case Report and Review of the Literature.Mycopathologia. 2016 Aug;181(7-8):589-93. doi: 10.1007/s11046-016-0006-7. Epub 2016 Apr 1. Mycopathologia. 2016. PMID: 27038312 Review.
Cited by
-
One year prospective survey of Candida bloodstream infections in Scotland.J Med Microbiol. 2007 Aug;56(Pt 8):1066-1075. doi: 10.1099/jmm.0.47239-0. J Med Microbiol. 2007. PMID: 17644714 Free PMC article.
-
Novel 5-flucytosine-resistant clade of Candida dubliniensis from Saudi Arabia and Egypt identified by Cd25 fingerprinting.J Clin Microbiol. 2005 Aug;43(8):4026-36. doi: 10.1128/JCM.43.8.4026-4036.2005. J Clin Microbiol. 2005. PMID: 16081946 Free PMC article.
-
First isolation of Candida dubliniensis from oral cavities of dermatological patients in Nanjing, China.Mycopathologia. 2011 Dec;172(6):465-71. doi: 10.1007/s11046-011-9447-1. Epub 2011 Jul 17. Mycopathologia. 2011. PMID: 21769632
-
Exploring the Biology, Virulence, and General Aspects of Candida dubliniensis.Infect Drug Resist. 2024 Dec 21;17:5755-5773. doi: 10.2147/IDR.S497862. eCollection 2024. Infect Drug Resist. 2024. PMID: 39722735 Free PMC article. Review.
-
Tobacco agar, a new medium for differentiating Candida dubliniensis from Candida albicans.J Clin Microbiol. 2004 Oct;42(10):4796-8. doi: 10.1128/JCM.42.10.4796-4798.2004. J Clin Microbiol. 2004. PMID: 15472343 Free PMC article.
References
-
- Al-Hedaithy, S. S. A., and R. Fotedar. 2002. Recovery and studies on chlamydospore-negative Candida albicans isolated from clinical specimens. Med. Mycol. 40:301-306. - PubMed
-
- Boyle, B. M., D. J. Sullivan, C. Forkin, F. Mulcahy, C. T. Keane, and D. C. Coleman. 2002. Candida dubliniensis candidemia in an HIV-positive patients in Ireland. Int. J. Sex. Transm. Dis. AIDS 1:55-57. - PubMed
-
- Coleman, D., D. Sullivan, K. Haynes, M. Henman, D. Shanley, D. Bennett, G. Moran, C. McCreary, L. O. Neill, and B. Harrington. 1997. Molecular and phenotypic analysis of Candida dubliniensis: a recently identified species linked with oral candidosis in HIV-infected and AIDS patients. Oral Dis. 3(Suppl.):S96-S101. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources